300
Participants
Start Date
August 2, 2018
Primary Completion Date
June 30, 2019
Study Completion Date
July 31, 2019
Spectroscopy for Analyte Quantification
Diabetic hospital staff participants subjected to the KBS-1 device (Test Article #01) will have a finger on their left hand pricked with a lancet and their blood glucose level read by a POC glucose monitor (Control Article #02). Next, they will have their interstitial fluid glucose level spectroscopically scanned from the palm of their left hand using the KBS-1 device, and blood (approximately 40µl), collected from their finger prick site, will be spectroscopically scanned using the RBA-1 device (Test Article #02). Hospital patients subjected to the RBA-1 device, who must already be prescribed a hospital lab blood test by their physician, will have approximately 40µl of their blood, collected from the venipuncture site, spectroscopically scanned using the RBA-1 device (Test Article #02).
RECRUITING
Florida Hospital Tampa, Tampa
Collaborators (1)
Kaligia Biosciences, LLC
INDUSTRY
Florida Hospital Tampa Bay Division
OTHER